Early Detection Research Network

Prediction of patient-specific risk and percentile cohort risk of pathological stage outcome using continuous prostate-specific antigen measurement, clinical stage and biopsy Gleason score.

No abstract available.

Chun FK, Epstein JI, Feng Z, Haese A, Han M, Huang Y, Humphreys E, Isharwal S, Makarov DV, Partin AW, Veltri RW


BJU Int., 2011, 107 (10)